newsfilter
← Latest News
GlobeNewswire·

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. ((‘Century', NASDAQ:IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in